CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Fishman Peter L. SVP, CFO | Shares withheld for taxes | −62 | $14.46 | $897 | 6,220 |
| 2026-04-01 | Fishman Peter L. SVP, CFO | Option exercise · Restricted Stock Unit | +125 | 0 | ||
| 2026-02-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +8,013 | 8,013 | ||
| 2026-02-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +36,060 | 36,060 | ||
| 2026-02-01 | Berg Aaron President and CEO | Grant or award · Restricted Stock Unit | +26,793 | 26,793 | ||
| 2026-02-01 | Berg Aaron President and CEO | Grant or award · Stock Option (right to buy) | +120,566 | 120,566 | ||
| 2026-02-01 | Provoost Jonathan EVP, Chief Legal Officer | Grant or award · Restricted Stock Unit | +8,013 | 8,013 | ||
| 2026-02-01 | Provoost Jonathan EVP, Chief Legal Officer | Grant or award · Stock Option (right to buy) | +36,060 | 36,060 | ||
| 2026-02-01 | Fishman Peter L. SVP, CFO | Grant or award · Restricted Stock Unit | +6,167 | 6,167 | ||
| 2026-02-01 | Fishman Peter L. SVP, CFO | Grant or award · Stock Option (right to buy) | +27,750 | 27,750 | ||
| 2026-02-01 | Keenan David Paul EVP, Chief Operating Officer | Grant or award · Restricted Stock Unit | +8,013 | 8,013 | ||
| 2026-02-01 | Keenan David Paul EVP, Chief Operating Officer | Grant or award · Stock Option (right to buy) | +30,060 | 30,060 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +2,246 | 41,243 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,235 | $15.42 | $19K | 40,008 |
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +1,933 | 41,941 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,062 | $15.42 | $16K | 40,879 |
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise · Restricted Stock Unit | +2,246 | 0 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise · Restricted Stock Unit | +1,933 | 1,933 | ||
| 2026-01-31 | Berg Aaron President and CEO | Option exercise | +2,246 | 82,960 | ||
| 2026-01-31 | Berg Aaron President and CEO | Shares withheld for taxes | −1,235 | $15.42 | $19K | 81,725 |
Page 3 of 67 · 1,339 trades